FSRH CEU statement: Cerebral venous sinus thrombosis AstraZeneca COVID-19 vaccination and CHC
The FSRH CEU has issued a statement which examines the available evidence and provides recommendations in relation to the association between cerebral venous sinus thrombosis, AstraZeneca COVID-19 vaccination and combined hormonal contraception (CHC).
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
